EYEG News and Press, Eyegate Pharmaceuticals Inc. From 07/14/20

WALTHAM, MA / ACCESSWIRE / July 14, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that based on feedback from a meeting with the U.S. Food and Drug Ad...

WALTHAM, MA / ACCESSWIRE / June 11, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that it has received positive feedback from the U.S. Food and Drug A...

WALTHAM , MA / ACCESSWIRE / June 1, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that its Chief Executive Officer, Stephen From, will be presenting ...

WALTHAM, MA / ACCESSWIRE / May 6, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, today announced financial results for the quarter ended March 31, 2020 and provided an...

Gainers: Trevi Therapeutics (NASDAQ: TRVI ) +109% . More news on: Trevi Therapeutics, Inc., SG Blocks, Inc., Greenland Technologies Holding Corporation, Stocks on the move, , Read more ...

SG Blocks (NASDAQ: SGBX ) +100%  on Q4 results .. More news on: SG Blocks, Inc., EyeGate Pharmaceuticals, Inc., Kiniksa Pharmaceuticals, Ltd., Stocks on the move, , Read more ...

Thinly traded nano cap EyeGate Pharmaceuticals (NASDAQ: EYEG ) jumps  71%  premarket on increased volume in reaction to positive data from an investigator-masked 20-subject (40 eyes) study comparing its Ocular Bandage Gel (OBG) eye drop to Allergan's (NYSE: AGN ) Refresh Preserva...

WALTHAM, MA / ACCESSWIRE / March 31, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that it has received positive topline data in its study using the O...

Gainers : Rexahn Pharmaceuticals (NASDAQ: REXN )  +85% . More news on: Rexahn Pharmaceuticals, Inc., Sprint Corporation, Genprex, Inc., Stocks on the move, , Read more ...

EyeGate Pharmaceuticals (NASDAQ: EYEG ) hits the enrollment target in a follow-on pilot study evaluating its Ocular Bandage Gel eye drop in patients with punctate epitheliopathies, mainly dry eye. More news on: EyeGate Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, ...